For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...
The recent decision to merge Genentech’s two cancer departments was made for “scientific reasons,” executives explained to ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Genentech, a leading biotechnology company, recently announced the permanent closing of their Cancer Immunology Department. This announcement comes as a major surprise in the scientific community.
Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche ...
On Genentech's website, the company notes that its large South San Francisco campus encompasses scientific research, manufacturing and “various business functions.” Earlier this month ...
Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
San Francisco Chronicle on MSN5mon
Bay Area biotech giants Genentech and Sanofi to lay off more than 500 employeesThe company, valued at $6.2 billion in October 2021, has approximately 1,700 employees, according to a LinkedIn estimate, ...
The FDA approval is based on data from Genentech's Phase IB/III IMscin001 study, according to the company, which showed comparable levels of Tecentriq in the blood, "when administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback